All posts by: Michael Zand

About Michael Zand

Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718 – The Herald | HeraldOnline.com (press release)

Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718The Herald | HeraldOnline.com (press release)CAMBRIDGE, Mass. — Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it has acquired the license to VS-4718 held originally by Poniard … and more …read more   &nbs… Continue reading

2014-02-25 NEWS

Kerry Simon finishes second round of stem-cell treatments, finalizes plans for … – Las Vegas Sun

Kerry Simon finishes second round of stem–cell treatments, finalizes plans for …Las Vegas Sun“Iron Chef America” winner Kerry Simon wrapped up his second round of stem–cell transplants Sunday at the Mayo Clinic in Rochester, Minn., and returns here today to put the final touches on his Fight MSA fundraiser Thursday at our downtown Keep Memory … Continue reading

2014-02-25 NEWS